USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression
Molecular Oncology · 2024-01 · 18 (1) · 170-189
DOI: 10.1002/1878-0261.13543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 02.11.2023. Verfasst von Xiaojia Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong Univers…. Hauptthemen laut MEDLINE: Neoplasms, Ribonuclease III. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China's National Key R&D Programmes, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.
Abstract (Originalsprache)
Endoribonuclease DICER is an RNase III enzyme that mainly processes microRNAs in the cytoplasm but also participates in nuclear functions such as chromatin remodelling, epigenetic modification and DNA damage repair. The expression of nuclear DICER is low in most human cancers, suggesting a tight regulation mechanism that is not well understood. Here, we found that ubiquitin carboxyl‐terminal hydrolase 7 (USP7), a deubiquitinase, bounded to DICER and reduced its nuclear protein level by promoting its ubiquitination and degradation through MDM2, a newly identified E3 ubiquitin‐protein ligase for DICER. This USP7‐MDM2‐DICER axis impaired histone γ‐H2AX signalling and the recruitment of DNA damage response (DDR) factors, possibly by influencing the processing of small DDR noncoding RNAs. We also showed that this negative regulation of DICER by USP7 via MDM2 was relevant to human tumours using cellular and clinical data. Our findings revealed a new way to understand the role of DICER in malignant tumour development and may offer new insights into the diagnosis, treatment and prognosis of cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, China.
- Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, China.
ORCID-Profile: Ruiyu Xie, Xian Zhao, Jianxiu Yu
Förderung
- China's National Key R&D Programmes
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Science and Technology Development Fund, Macau SAR
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Liu, X., Lu, R., Yang, Q., He, J., Huang, C., Cao, Y., Zhou, Z., Huang, J., Li, L., Chen, R., Wang, Y., Huang, J., Xie, R., Zhao, X., & Yu, J. (2024). USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression. Molecular Oncology, 18(1), 170-189. https://doi.org/10.1002/1878-0261.13543
Vancouver
Liu X, Lu R, Yang Q, He J, Huang C, Cao Y, et al. USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression. Molecular Oncology. 2024;18(1):170-189. doi:10.1002/1878-0261.13543
BibTeX
@article{Liu2024,
author = {Liu, Xiaojia and Lu, Runhui and Yang, Qianqian and He, Jianfeng and Huang, Caihu and Cao, Yingting and Zhou, Zihan and Huang, Jiayi and Li, Lian and Chen, Ran and Wang, Yanli and Huang, Jian and Xie, Ruiyu and Zhao, Xian and Yu, Jianxiu},
title = {USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression},
journal = {Molecular Oncology},
year = {2024},
volume = {18},
number = {1},
pages = {170--189},
doi = {10.1002/1878-0261.13543}
}
EUVIMED